BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3039183)

  • 1. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity.
    Li JS; Zhou BS; Dutschman GE; Grill SP; Tan RS; Cheng YC
    J Virol; 1987 Sep; 61(9):2947-9. PubMed ID: 3039183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
    Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies.
    Dölken G; Hecht T; Röckel D; Hirsch FW
    Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigens.
    Dölken G; Hecht T; Weitzmann U; Wagner M; Löhr GW; Hirsch FW
    Virology; 1986 Jan; 148(1):58-73. PubMed ID: 3002036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
    Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.
    Kallin B; Sternås L; Saemundssen AK; Luka J; Jörnvall H; Eriksson B; Tao PZ; Nilsson MT; Klein G
    J Virol; 1985 May; 54(2):561-8. PubMed ID: 2985818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
    Tsai CH; Williams MV; Glaser R
    Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immune serum to the Epstein-Barr virus DNA polymerase.
    Petit RG; Leung K; Shaw JE
    J Virol; 1987 Oct; 61(10):3331-4. PubMed ID: 3041054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein.
    Cho MS; Milman G; Hayward SD
    J Virol; 1985 Dec; 56(3):860-6. PubMed ID: 2999442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of Epstein-Barr virus-induced ribonucleotide reductase with antibody to the major restricted early antigen polypeptide.
    Goldschmidts WL; Ginsburg M; Pearson GR
    Virology; 1989 May; 170(1):330-3. PubMed ID: 2541553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells.
    Epstein AL
    J Virol; 1984 May; 50(2):372-9. PubMed ID: 6323737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes.
    Lin JC; Pagano JS
    J Virol; 1986 Aug; 59(2):522-4. PubMed ID: 3016315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
    Allaudeen HS
    Antiviral Res; 1985 Feb; 5(1):1-12. PubMed ID: 2984987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of EA-D of Epstein-Barr virus.
    Chen LW; Lin LS; Chang YS; Liu ST
    Virology; 1995 Aug; 211(2):593-7. PubMed ID: 7645263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an Epstein-Barr virus-induced DNA polymerase.
    Ooka T; Lenoir G; Daillie J
    J Virol; 1979 Jan; 29(1):1-10. PubMed ID: 219209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines.
    Allaudeen HS; Rani G
    Nucleic Acids Res; 1982 Apr; 10(7):2453-65. PubMed ID: 6283481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.